By Nissan Chemical Corporation
Manufacturing of APIs and intermediates from pre-clinical stage to commercial production; Manufacturing under cGMP (we have experiences receiving audit from PMDA, FDA, EU and other organizations outside of Japan); Manufacturing of high potency active pharmaceutical ingredients requiring containment; We have the capacity of bulk manufacturing of hundreds of kilograms and small scale manufacturing of several grams; Purification using large-scale preparative columns.
